INTELLIA THERAPEUTICS, INC. Shares Outstanding (Cover Page)
INTELLIA THERAPEUTICS, INC. (NTLA) had Shares Outstanding (Cover Page) of 140.13 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 140.13M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 139.72M shares.
- 2026-02-13: Entity Common Stock, Shares Outstanding 118.13M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 115.83M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 140.13M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 139.72M shares 10-Q · filed 2026-05-11 |
| 2026-02-13 | 118.13M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 115.83M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 107.35M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 103.58M shares 10-Q · filed 2025-05-08 |
| 2025-02-14 | 103.52M shares 10-K · filed 2025-02-27 |
| 2024-11-01 | 101.85M shares 10-Q · filed 2024-11-07 |
| 2024-08-02 | 101.58M shares 10-Q · filed 2024-08-08 |
| 2024-05-03 | 96.48M shares 10-Q · filed 2024-05-09 |
| 2024-02-16 | 96.11M shares 10-K · filed 2024-02-22 |
| 2023-11-03 | 89.55M shares 10-Q · filed 2023-11-09 |
| 2023-07-28 | 88.49M shares 10-Q · filed 2023-08-03 |
| 2023-04-28 | 88.14M shares 10-Q · filed 2023-05-04 |
| 2023-02-17 | 88.02M shares 10-K · filed 2023-02-23 |
| 2022-10-31 | 78.68M shares 10-Q · filed 2022-11-03 |
| 2022-08-01 | 76.01M shares 10-Q · filed 2022-08-04 |
| 2022-04-28 | 75.85M shares 10-Q · filed 2022-05-05 |
| 2022-02-17 | 74.67M shares 10-K · filed 2022-02-24 |
| 2021-10-29 | 74.42M shares 10-Q · filed 2021-11-04 |
| 2021-07-30 | 73.49M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 68.15M shares 10-Q · filed 2021-05-06 |
| 2021-02-19 | 67.73M shares 10-K · filed 2021-02-26 |
| 2020-10-30 | 59.08M shares 10-Q · filed 2020-11-05 |
| 2020-07-31 | 58.74M shares 10-Q · filed 2020-08-06 |
| 2020-05-01 | 51.38M shares 10-Q · filed 2020-05-07 |
| 2020-02-21 | 50.51M shares 10-K · filed 2020-02-27 |
| 2019-10-25 | 48.88M shares 10-Q · filed 2019-10-31 |
| 2019-07-26 | 48.54M shares 10-Q · filed 2019-08-01 |
| 2019-04-30 | 45.71M shares 10-Q · filed 2019-05-02 |
| 2019-02-22 | 45.23M shares 10-K · filed 2019-02-27 |
| 2018-10-26 | 43.42M shares 10-Q · filed 2018-10-31 |
| 2018-07-27 | 43.20M shares 10-Q · filed 2018-08-01 |
| 2018-04-27 | 43.09M shares 10-Q · filed 2018-05-01 |
| 2018-02-28 | 42.39M shares 10-K · filed 2018-03-14 |
| 2017-10-27 | 36.09M shares 10-Q · filed 2017-10-31 |
| 2017-07-28 | 36.11M shares 10-Q · filed 2017-08-01 |
| 2017-04-26 | 36.03M shares 10-Q · filed 2017-05-02 |
| 2017-02-28 | 36.02M shares 10-K · filed 2017-03-14 |
| 2016-10-28 | 36.00M shares 10-Q · filed 2016-11-01 |
| 2016-08-02 | 36.00M shares 10-Q · filed 2016-08-04 |
| 2016-06-02 | 36.00M shares 10-Q · filed 2016-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |